<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>Bridget Draper for assisting with the manuscript preparation.</p>
 <sec id="d29e1228">
  <title>Funding</title>
  <p>Margaret Hellard is supported by a National Health and Medical Research Council (NHMRC) Principal Research Fellowship.</p>
  <p>Margaret Hellard receives funding from Gilead Sciences, Abbvie and BMS for investigator-initiated independent research. The Burnet Institute receives support from the Victorian Operational Infrastructure Support Program. No funding was received for the writing of this commentary, and no funders were involved in the decision to submit it for publication.</p>
  <p>Publication of this article was funded by the World Health Organization.</p>
 </sec>
 <sec id="d29e1237">
  <title>Availability of data and materials</title>
  <p id="Par14">Not applicable</p>
 </sec>
 <sec id="FPar2">
  <title>About this supplement</title>
  <p id="Par15">This article has been published as part of BMC Infectious Diseases Volume 17 Supplement 1, 2017: Testing for chronic hepatitis B and C â€“ a global perspective. The full contents of the supplement are available online at 
   <ext-link ext-link-type="uri" xlink:href="https://bmcinfectdis.biomedcentral.com/articles/supplements/volume-17-supplement-1" xmlns:xlink="http://www.w3.org/1999/xlink">https://bmcinfectdis.biomedcentral.com/articles/supplements/volume-17-supplement-1</ext-link>.
  </p>
 </sec>
</ack>
